Publication Date: 21 Jan 2010
Type: Original Research
Citation: Clinical Medicine: Endocrinology and Diabetes 2009:2 89-97
Background: The aim of this study is to evaluate the prevalence of chronic complications in type 2 diabetic patients in Basrah (Southern Iraq).
Methods: This was a longitudinal descriptive study for patients with diabetes registered in Al-Faiha Diabetes and Endocrine Centre in Basrah (Southern Iraq) for the period from April 2003 to end of February 2009.
Results: Out of 4,926 patients enrolled, 51.0% were women, mean age was 55.0 ± 13.1 years and 67.6% were overweight or obese. Those with duration of diabetes more than 5 years constituted 50.6% and only 25.3% were on insulin. Mean Hemoglobin A1C was 9.3 ± 2.0. The prevalence of the 16 complications studied were as follows: Hypertension in 31.0%, peripheral neuropathy in 13.8%, ischemic heart disease in 7.8%, proteinuria in 6.6%, cereberovascular accident in 4.6%, interdigital fungal infection in 4.3%, heart failure in 3.4%, and erectile dysfunction in 6.0%. In this study 2.8% of patients died of cardiovascular causes, 2.7% developed diabetic foot, 2.4% had non-alcoholic fatty liver, 0.7% had amputation, 0.4% developed ophthalmoplegia, 0.2% had peripheral vascu- lar disease, and 0.04% developed mucormycosis. The chronic complications which were more seen in those with diabetes more than 5 years were hypertension, peripheral neuropathy, ischemic heart disease, proteinuria, cereberovascular accident, heart failure, erectile dysfunction, cardiovascular death, diabetic foot, amputation and peripheral vascular disease.
Conclusion: This study provided the baseline for chronic complications of diabetes in Iraq. Screening for early complications is recommended.
PDF (527.77 KB PDF FORMAT)
RIS citation (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)
BibTex citation (BIBDESK, LATEX)
I would like to congratulate Clinical Medicine Insights: Endocrinology and Diabetes for the professional way it manages the entire publication process. I am certain it will have a bright future, and reach top positions among endocrine and metabolic journals.
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.See Our Results
Copyright © 2013 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)